Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003587585 | SCV004310043 | pathogenic | Jeune thoracic dystrophy | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile3617Asnfs*3) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). This variant is present in population databases (rs766275230, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DYNC2H1-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005047701 | SCV005680482 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-02-17 | criteria provided, single submitter | clinical testing |